Standout Papers
Citation Impact
Citing Papers
Excitatory amino acid antagonists for acute stroke
2003
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
2013
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
2007 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Adherence to HAART Regimens
2003
Cytochrome P450 2B6: function, genetics, and clinical relevance
2012
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
2014 Standout
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines
2013
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
2009
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Delayed Upregulation of ATP P2X3 Receptors of Trigeminal Sensory Neurons by Calcitonin Gene-Related Peptide
2006
Pharmacological Characterization of Ro 63-1908 (1-[2-(4-Hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a Novel Subtype-Selective N-Methyl-d-Aspartate Antagonist
2002
Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution
2008
Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients
2007
The Nonpeptide Calcitonin Gene-Related Peptide Receptor Antagonist BIBN4096BS Lowers the Activity of Neurons with Meningeal Input in the Rat Spinal Trigeminal Nucleus
2005
Phase-Separation Perspective on Dynamic Heterogeneities in Glass-Forming Liquids
2010 StandoutNobel
Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study
2009
The impact of vaccines on pneumonia: Key lessons from Haemophilus influenzae type b conjugate vaccines
2008
How well do clinicians estimate patients’ adherence to combination antiretroviral therapy?
2002
Calcitonin Gene‐Related Peptide Does Not Cause Migraine Attacks in Patients With Familial Hemiplegic Migraine
2011
NMDA receptors in clinical neurology: excitatory times ahead
2008
Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat
2004
Barriers to HAART Adherence Among Human Immunodeficiency Virus–Infected Adolescents
2003
Channel opening and gating mechanism in AMPA-subtype glutamate receptors
2017 StandoutNatureNobel
The Role of Dopamine in a Model of Trigeminovascular Nociception
2005
A multicentre assessment of the specificity of ten anti‐HBc screening tests
1995
High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection
1995
Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression
2008
Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane
2009 StandoutNobel
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists
2005
Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
2002
Animal models of migraine: looking at the component parts of a complex disorder
2006
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier
2014
Neuroprotection for ischemic stroke: Past, present and future
2008
Orexin 1 Receptor Activation Attenuates Neurogenic Dural Vasodilation in an Animal Model of Trigeminovascular Nociception
2005
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potential
2009
HLA-B*5701 Screening for Hypersensitivity to Abacavir
2008 Standout
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
2014
Unveiling thermal transitions of polymers in subnanometre pores
2010 StandoutNobel
NEUROGENIC INFLAMMATION AND MIGRAINE: IMPLICATIONS FOR THE THERAPEUTICS
2005
Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus
2010
Efavirenz in the therapy of HIV infection
2009
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization
2012
Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults
2001
Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance 1 1Edited by J. Karn
1998
Calcitonin gene-related peptide: A molecular link between obesity and migraine?
2010
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain
2007
Migraine headache is not associated with cerebral or meningeal vasodilatation—a 3T magnetic resonance angiography study
2008
Glial and neuronal control of brain blood flow
2010 StandoutNature
Antiretroviral Drug Resistance: Mechanisms, Pathogenesis, Clinical Significance
1996
Tipranavir
2008
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients
2004
Near-Field Photochemical Imaging of Noble Metal Nanostructures
2005
Modulation of CGRP-Induced Light Aversion in Wild-Type Mice by a 5-HT1B/DAgonist
2012
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat
2010
mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene–related peptide in the rat trigeminovascular system
2012
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Current practice and future directions in the prevention and acute management of migraine
2010
Role of Temperature in Controlling Performance of Photorefractive Organic Glasses
2003 StandoutNobel
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
The Dichotomy of NMDA Receptor Signaling
2007
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
2008
New FDA Regulation to Improve Safety Reporting in Clinical Trials
2011
AIDS across Europe, 1994–98: the EuroSIDA study
2000
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Neuroprotection in Cerebral Ischaemia: Facts and Fancies – The Need for New Approaches
2003
Relation between Heterogeneous Frozen Regions in Supercooled Liquids and Non-Debye Spectrum in the Corresponding Glasses
2019 StandoutNobel
Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
2009
Anandamide Is Able to Inhibit Trigeminal Neurons Using an in Vivo Model of Trigeminovascular-Mediated Nociception
2004
Long‐Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
2010
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
2014
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
2005 StandoutNature
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
2006 StandoutNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Structural Bases of Desensitization in AMPA Receptor-Auxiliary Subunit Complexes
2017 StandoutNobel
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
2012
Diencephalic and brainstem mechanisms in migraine
2011
Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion
2010
CGRP and its receptors provide new insights into migraine pathophysiology
2010
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Calcitonin gene–related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraine
2005
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Abacavir-Lamivudine-Zidovudine vs Indinavir-Lamivudine-Zidovudine in Antiretroviral-Naive HIV-Infected Adults<SUBTITLE>A Randomized Equivalence Trial</SUBTITLE>
2001
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
2007
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
2002
Post-endocytic Sorting of Calcitonin Receptor-like Receptor and Receptor Activity-modifying Protein 1
2007
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study
2013
Adherence to Medication
2005 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Elucidation of AMPA receptor–stargazin complexes by cryo–electron microscopy
2016 StandoutScienceNobel
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
2014
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse
2011
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
2010
Pituitary adenylate cyclase activating polypeptide and migraine
2014
Therapeutic drug monitoring of antiretrovirals for people with HIV
2009
The Blood-Brain Barrier in Migraine Treatment
2008
Pearls and pitfalls in experimental in vivo models of migraine: Dural trigeminovascular nociception
2013
Effects of Viscoelastic Properties on the Dielectric and Electrooptic Responses of Low-TgGuest−Host Polymers
2003
Calcitonin Gene-Related Peptide Receptor Inhibition Reduces Neuronal Activity Induced by Prolonged Increase in Nitric Oxide in the Rat Spinal Trigeminal Nucleus
2008
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
2013
Worldwide Variation in Human Drug-Metabolism Enzyme GenesCYP2B6andUGT2B7: Implications for HIV/AIDS Treatment
2012
Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
2019
Functional and molecular characterization of prostaglandin E2dilatory receptors in the rat craniovascular system in relevance to migraine
2010
Determination of coupled acid catalysis-diffusion processes in a positive-tone chemically amplified photoresist
2000
Spectroscopic Rationale for Efficient Stimulated-Emission Depletion Microscopy Fluorophores
2010 StandoutNobel
Antiretroviral adherence interventions: a review of current literature and ongoing studies.
2004
Development and Homeostasis of T Cell Memory in Rhesus Macaque
2002
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
Spatially Heterogeneous Dynamics in Supercooled Liquids
2000 Standout
Can density or entropy fluctuations explain enhanced translational diffusion in glass-forming liquids?
1998
Dual-use chromophores for photorefractive and irreversible photochromic applications
2001
(C2) Saliva, Breast Milk, and Mucosal Fluids in HIV Transmission
2006
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
2012
Toward Wisdom From Failure
2002
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons
2015
Glass Transition in Liquids: Two versus Three-Dimensional Confinement
1998
Antibacterial and biocompatible surfaces based on dopamine autooxidized silver nanoparticles
2012
Obesity, migraine, and chronic migraine
2007
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial
2010
Organic Photorefractives: Mechanisms, Materials, and Applications
2004 StandoutNobel
Random pinning glass model
2013 StandoutNobel
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
CGRP Release and c-fos Expression within Trigeminal Nucleus Caudalis of the Rat following Glyceryltrinitrate Infusion
2005
New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma
2003
A Potential Preclinical Migraine Model: CGRP-Sensitized Mice.
2009
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
2014
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
2004 StandoutNobel
Supercooled liquids and the glass transition
2001 StandoutNature
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS
2005 StandoutNobel
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
2011
Development of Two Complementary Syntheses for a Privileged CGRP Receptor Antagonist Substructure
2012
Spatially heterogeneous dynamics investigated via a time-dependent four-point density correlation function
2003
Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine
2008
High Efficiency Up‐Converting Single Phase Elastomers for Photon Managing Applications
2013
Effects of confinement on material behaviour at the nanometre size scale
2005
Prostaglandin I2(epoprostenol) triggers migraine-like attacks in migraineurs
2009
The distribution of glass-transition temperatures in nanoscopically confined glass formers
2003
Latent reservoirs of HIV: Obstacles to the eradication of virus
1999
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
2007
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
2010
Toward Nanometer-Scale Optical Photolithography: Utilizing the Near-Field of Bowtie Optical Nanoantennas
2006 StandoutNobel
High-Temperature Water Adsorption Isotherms and Ambient Temperature Water Diffusion Rates on Water Harvesting Metal–Organic Frameworks
2024 StandoutNobel
Single Molecule Probing of the Local Segmental Relaxation Dynamics in Polymer above the Glass Transition Temperature
2009
Adherence to HAART among patients with HIV: Breakthroughs and barriers
2002
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
2016
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Recruiting Subjects for Acute Stroke Trials
2005
Discrepancy between strong cephalic arterial dilatation and mild headache caused by prostaglandin D2(PGD2)
2010
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
2014
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
2010
Human immunodeficiency virus–driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients
2004
Heterogeneity at the glass transition: a review
1999
Works of David B. Hall being referenced
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
2011
A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials
2005
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy
1999
Aptiganel Hydrochloride in Acute Ischemic Stroke
2001
Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine
2011
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
2001
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy
1998
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients
1998
PHARYNGEAL CARRIAGE AND ACQUISITION OF ANTICAPSULAR ANTIBODY TO HAEMOPHILUS INFLUENZAE TYPE b IN A HIGHRISK POPULATION IN SOUTHWESTERN ALASKA
1987
Case-Control Exploration of Relationships Between Early Rash or Liver Toxicity and Plasma Concentrations of Nevirapine and Primary Metabolites
2007
Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis b infection in a population with a high prevalence of hepatitis B
1990
Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1
2004
A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1
2003
Phase I/II Evaluation of Nevirapine Alone and in Combination with Zidovudine for Infection with Human Immunodeficiency Virus
1995
Probe translational and rotational diffusion in polymers near Tg: roles of probe size, shape, and secondary bonding in deviations from Debye–Stokes–Einstein scaling
1998
Spin coating of thin and ultrathin polymer films
1998
Genotypic Changes in Human Immunodeficiency Virus Type 1 Protease Associated with Reduced Susceptibility and Virologic Response to the Protease Inhibitor Tipranavir
2006
Planning and core analyses for periodic aggregate safety data reviews
2011
Mass transfer in atmospheric water harvesting systems
2023 StandoutNobel
Translation-Rotation Paradox for Diffusion in Glass-Forming Polymers: The Role of the Temperature Dependence of the Relaxation Time Distribution
1997
Ultrathin Polymer Films near the Glass Transition: Effect on the Distribution of α-Relaxation Times As Measured by Second Harmonic Generation
1997
Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team
2009